Hover to zoom
GLP-1 & MetabolicSynthetic research compound
Cagrilintide / Semaglutide
$119.99
5/5 mgThis preparation supplies cagrilintide and semaglutide together in a single lyophilized vial. Cagrilintide is an amylin analog acting at amylin receptor complexes; semaglutide is a GLP-1 receptor agonist.
Combined preparations are used in laboratory research where investigators want to study two distinct metabolic signaling pathways in the same experimental condition rather than preparing each material separately.
Research areas
Amylin receptor signalingGLP-1 receptor signalingCombined-pathway researchPreclinical research
Form: Lyophilized (freeze-dried)
- Compound class
- Synthetic research compound
- Research category
- GLP-1 & Metabolic
- SKU
- NVR-CAGRILINTIDE-SEMAGLUTIDE-5-5MG
- Appearance
- Lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
5/5 mg$119.99$12.00/mg
1
$119.99per 5/5 mg$12.00/mg
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know
More detail on Cagrilintide / Semaglutide.
Analytical values reflect per-lot documentation and appear once a batch is released.
Compound
Multi-compound research preparations are convenient when an experimental design calls for a fixed relationship between two agonists across many samples. Here, the amylin and incretin pathways converge on overlapping areas of metabolic regulation but act through separate receptor systems, so co-presentation lets researchers observe pathway interaction directly. Because the two compounds are supplied together, they cannot be varied independently; studies requiring separate ratios should use the individual materials. Research involving combined receptor agonism is exploratory and conducted in vitro or in preclinical models.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
Cagrilintide / Semaglutide is studied within its research category (GLP-1 & Metabolic) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
Amylin receptor signalingGLP-1 receptor signalingCombined-pathway researchPreclinical research
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
Scientific background
Cagrilintide / Semaglutide is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.
Related
View all →Related research materials
Cagrilintide
10 mg
Long-acting amylin analog studied for amylin and calcitonin receptor signaling in laboratory models.
$99.99
DetailsHGH Fragment 176-191
5 mg
Unmodified C-terminal growth-hormone fragment used in comparative adipose-tissue research.
$69.99
DetailsRetatrutide
4 strengths available
Triple agonist peptide targeting GIP, GLP-1, and glucagon receptors in preclinical metabolic research.
Up to 64% lower per mg
from$59.99
DetailsCagrilintide / Semaglutide
5/5 mg · $119.99